Tetraethylammonium inhibits glioma cells via increasing production of intracellular reactive oxygen species

Chemotherapy

Volumn 55, Issue 5, 2009, Pages 372-380

  Yang, K B ^a   Zhao, S G ^a   Liu, Y H ^a   Hu, E X ^a   Liu, B X ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glioma; Potassium channel blockers; Reactive oxygen species; Tetraethylammonium

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TETRYLAMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; FLOW CYTOMETRY; GLIOMA CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; POTASSIUM CHANNEL BLOCKERS; RATS; REACTIVE OXYGEN SPECIES; TETRAETHYLAMMONIUM;

EID: 69049084827     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235730     Document Type: Article

References (43)

1. + channels in human T lymphocytes: a role in mitogenesis? Nature 1984;307:465-468.
2. Nilius B, Wohlrab W: Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 1992;445:537-548.
3. Basrai D, Kraft R, Bollensdorff C, et al: BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport 2002;13:403-407. (Pubitemid 34293178)
4. Kayser ST, Ulrich H, Schaller HC: Involvement of a Gardos-type potassium channel in head activator-induced mitosis of BON cells. Eur J Cell Biol 1998;76:119-124. (Pubitemid 28312634)
5. Liu SI, Chi CW, Lui WY, et al: Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells. Biochim Biophys Acta 1998;1368:256-266.
6. Vaur S, Bressonbepoldin L, Dufy B, et al: Potassium channel inhibition reduces cell proliferation in the GH3 pituitary cell line. J Cell Physiol 1998;177:402-410. (Pubitemid 28524664)
7. + channels in human endothelial cells in culture. Int J Biochem Cell Biol 2001;33:337-346.
8. Utermark T, Alekov A, Lerche H, et al: Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells. Cancer 2003;97:1955-1962. (Pubitemid 36397271)
9. Abdul M, Hoosein N: Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002;186:99-105. (Pubitemid 35245332)
10. Akhtar S, McIntosh P, Bryan-Sisneros A, et al: A functional spliced-variant of beta 2 subunit of Kv1 channels in C6 glioma cells and reactive astrocytes from rat lesioned cerebellum. Biochemistry 1999;38:16984-16992. (Pubitemid 30013706)
11. Preussat K, Beetz C, Schrey M, et al: Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 2003;346:33-36. (Pubitemid 36792187)
12. Siemen D, Loupatatzis C, Borecky J, et al: Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun 1999;257:549-554. (Pubitemid 29301480)
13. + uptake in cultured human glioma cells. Cell Mol Neurobiol 1995;15:351-360.
14. Bordey A, Sontheimer H: Electrophysiological properties of human astrocytic tumor cells in situ: enigma of spiking glial cells. J Neurophysiol 1998;79:2782-2793. (Pubitemid 28261657)
15. + channel in malignant astrocytoma cell lines. J Neurosci Res 1997;48:122-127.
16. Brismar T, Collins VP: Potassium and sodium channels in human malignant glioma cells. Brain Res 1989;480:259-267. (Pubitemid 19050220)
17. Pallotta BS, Hepler JR, Oglesby SA, et al: A comparison of calcium-activated potassium channel currents in cell-attached and excised patches. J Gen Physiol 1987;89:985-997.
18. Ullrich N, Sontheimer H: Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am J Physiol Cell Physiol 1996;270:C1511-C1521. (Pubitemid 26181950)
19. Bakhramov A, Fenech C, Bolton TB: Chloride current activated by hypotonicity in cultured human astrocytoma cells. Exp Physiol 1995;80:379-389.
20. Wonderlin WF, Woodfork KA, Strobl JS, et al: Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 1995;165:177-185.
21. 2+ channels in CHP-100 cells. Neuroreport 1994;5:1256-1258.
22. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 2004;65:630-638.
23. + ion channel blockers. J Neurosci 1999;19:5942-5954.
24. Lohr JW, Yohe LA: Mechanisms of hypoosmotic volume regulation in glioma cells. Brain Res 1994;667:263-268.
25. Chittajallu R, Chen Y, Wang H, et al: Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 2002;99:2350-2355. (Pubitemid 34169064)
26. Itoi T, Shinohara Y, Takedak, et al: Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J Gastroenterol 2000;35:142-149. (Pubitemid 30129006)
27. Weaver AK, Liu X, Sontheimer H: Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 2004;78:224-234. (Pubitemid 39313795)
28. Wei L, Xiao AY, Jin C, et al: Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons. Pflügers Arch 2004;448:325-334. (Pubitemid 40895602)
29. + channel blocker, in HepG2 human hepatoblastoma cells. Pharmacology 2000;60:74-81.
30. Han MH, Yoo YH, Choi YH: Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy 2008;54:157-165. (Pubitemid 351929265)
31. Marchetti P, Castedo M, Susin SA, et al: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-1160. (Pubitemid 26313572)
32. Brooke RE, Moores TS, Morris NP, et al: Kv3 voltage-gated potassium channels regulate neurotransmitter release from mouse motor nerve terminals. Eur J Neurosci 2004;20:3313-3321.
33. Shinoda M, Toki Y, Murase K, et al: Types of potassium channels involved in coronary reactive hyperemia depend on duration of preceding ischemia in rat hearts. Life Sci 1997;61:997-1007. (Pubitemid 27348668)
34. 2+-activated potassium channels. J Cereb Blood Flow Metab 2003;23:1227-1238.
35. Nimmrich V, Grimm C, Draguhn A, et al: Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci 2008;28:788-797. (Pubitemid 351159014)
36. Wei L, Yu SP, Gottron F, et al: Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo. Stroke 2003;34:1281-1286. (Pubitemid 36547529)
37. Hu CL, Liu Z, Zeng XM, et al: 4-Aminopyridine, a Kv channel antagonist, prevents apoptosis of rat cerebellar granule neurons. Neuropharmacology 2006;51:737-746. (Pubitemid 44286928)
38. Han Y, Shi Y, Han Z, et al: Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells. Cell Biol Int 2007;31:741-747. (Pubitemid 46779089)
39. Forman HJ, Torres M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002;166:4-8.
40. Chakraborti T, Das S, Mondal M, et al: Oxidant, mitochondria and calcium: an overview. Cell Signal 1999;11:77-85.
41. Gerlach M, Ben-Shachar D, Riederer P, et al: Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.
42. Eskiocak U, Işeri OD, Kars MD, et al: Effect of doxorubicin on telomerase activity and apoptotic gene expression in doxorubicin-resistant and -sensitive MCF-7 cells: an experimental study. Chemotherapy 2008;54:209-216. (Pubitemid 351929272)
43. Park C, Kim GY, Kim WI, et al: Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells. Chemotherapy 2007;53:160-168.